Ophthalmic ciprofloxacin comes as a solution (liquid) to apply to the eyes. Ciprofloxacin ophthalmic solution is usually used often, between once every 15 minutes to once every four hours while awake for seven to 14 days or longer. Ciprofloxacin ophthalmic ointment is usually applied three times a day for two days and then twice a day for five days. Use ciprofloxacin ophthalmic at around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use ciprofloxacin ophthalmic exactly as directed. Do not use it more often than prescribed by your doctor.
You should expect your symptoms to improve during your treatment. Call your doctor if your symptoms do not go away or get worse, or if you develop other problems with your eyes during your treatment.
Use ophthalmic ciprofloxacin until you finish the prescription, even if you feel better. If you stop using ophthalmic ciprofloxacin too soon, your infection may not be completely cured and the bacteria may become resistant to antibiotics.
To instill the eye drops, follow these steps:
Wash your hands thoroughly with soap and water.
Check the dropper tip to make sure that it is not chipped or cracked.
Avoid touching the dropper tip against your eye or anything else; eyedrops and droppers must be kept clean.
While tilting your head back, pull down the lower lid of your eye with your index finger to form a pocket.
Hold the dropper (tip down) with the other hand, as close to the eye as possible without touching it.
Brace the remaining fingers of that hand against your face.
While looking up, gently squeeze the dropper soa single drop falls into the pocket made by the lower eyelid. Remove your index finger from the lower eyelid.
Close your eye for two to three minutes and tip your head down as though looking at the floor. Try not to blink or squeeze your eyelids.
Place a finger on the tear duct and apply gentle pressure.
Wipe any excess liquid from your face with a tissue.
If you are to use more than one drop in the same eye, wait at least five minutes before instilling the next drop.
Replace and tighten the cap on the dropper bottle. Do not wipe or rinse the dropper tip.
Wash your hands to remove any medication.
To apply the eye ointment, follow these instructions:
Avoid touching the tip of the tube against your eye or anything else; the tube tip must be kept clean.
Holding the tube between your thumb and forefinger, place it as near to your eyelid as possible without touching it.
Tilt your head backward slightly.
With your index finger, pull the lower eyelid down to form a pocket.
Squeeze a 1/2-inch (1.25cm) ribbon of ointment into the pocket made by the lower eyelid.
Blink your eye slowly; then gently close your eye for one to two minutes.
With a tissue, wipe any excess ointment from the eyelids and lashes. With another clean tissue, wipe the tip of the tube clean.
Replace and tighten the cap right away.
| Ophthalmic result | Easy to apply | Discontinue use and do not use for a longer time than prescribed. |
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Hospitalities in or around and areone to two-week-olds. Prescription only.See also Tizanidine Tablets.
Ciprofloxacin and tizanidine should be used with caution in patients with certain liver or kidney disease. Consult your doctor before using with other quinolones. Ciprofloxacin may cause dose-dependent peripheral neuropathy with the risk falling to few cases in patients with systemic pre-existing neuropathic disorders. Use with caution in patients with a history of myasthenia gravis. Use with caution in patients with a history of cerebrovascular disease. Monitor for myoclonus, ophthalmopathy, mydriasis, myophilia and diabetic retinitis. Contact your doctor if you notice ocular disorders, discuss your history of vision loss and concerns. Avoid consuming milk or dairy products. Antacids may reduce the effectiveness of ciprofloxacin. Avoid excessive alcohol consumption. For external use only. Avoid concomitantly taking other medications (e.g. barbiturates, anti-psychotic medications, monoamine oxidase inhibitors, centrally-acting antidepressants, diuretics) such as amitriptyline, cyclosporine, fosinopril, r worsen. In the case of an overdose, contact a Poison Control Center. Potentially Fatal: Severe CNS depression. Immediate medical attention is essential if symptoms arise. Avoid driving or operating machinery until you know how ciprofloxacin affects you. Consult your doctor. Caution is advised in patients with renal or hepatic impairment and in patients taking anticoagulants for high blood levels. Ciprofloxacin should be taken with caution in patients with a history of myasthenia gravis. Patients with known or suspected pre-existing neurological disorders may be treated withQuinolones before performing thorough diagnostic examinations. During pregnancy, breast-feeding, lactation, breastfeeding, adverse effects should be carefully considered before startingQuinolones. Discuss with your doctor the possibility of possible effects on the infant such as crying, irritability, changes in appetite, headache, abnormalities of brain structure or function. Dosage and duration of treatment are based on the patient’s medical condition and response to treatment. Do not increase your dose unless your doctor advises you to do so.
Treatment of infections and allergies is a common concern in all ages. While there are plenty of over-the-counter or prescription options available, most people find that they are often overwhelmed with their needs. In many cases, your doctor may suggest an antibiotic for your allergies or your condition, which you can then try to get right to the point. But in many cases, you may not be able to find a reliable treatment option.
In this article, we’ll take a look at some of the most common antibiotics and how they may help you. You may also find a variety of other things you can do to help you feel better. But don’t be afraid to ask your doctor if you can find a reliable solution.
Antibiotics are a class of antibiotics that are commonly used in the treatment of infections. They are effective in treating bacterial infections and allergies. However, there are some uses of antibiotics in treating other illnesses and allergies, such as acne or other allergies. Antibiotics work by stopping the growth of bacteria and other harmful organisms.
Some examples of antibiotics include:
Antibiotics are generally more effective when taken correctly, but it’s important to consult with your doctor before starting any new treatment. If you have a known allergy to penicillin, you may be more likely to get antibiotic resistance or side effects.
In many cases, you might find that you are unable to get or maintain an effective treatment plan. This is because there are different types of antibiotics in the treatment of infections. Antibiotics that you may be prescribed for other illnesses can interact with other medications, leading to side effects or even death. Therefore, in addition to finding the right antibiotic for your infection, you may want to try other treatments.
Many people may have allergies to antibiotics that are not specifically prescribed for their condition, such as those that are available in both oral and topical forms.
In the first case-cohort (i.e. all patients receiving ciprofloxacin-containing therapy) an antibiotic ciprofloxacin was given for up to six months, which is associated with an increase in the incidence of adverse events. Although the dose and length of ciprofloxacin treatment were not different between patients receiving ciprofloxacin and those receiving placebo, a higher incidence of adverse events was observed when the drug was given for longer periods of time. In the second case-cohort (i.e. all patients receiving ciprofloxacin-containing therapy) a higher incidence of adverse events was observed. The reason for this discrepancy between the two studies could be due to differences in the drug formulation or the use of different concentrations of ciprofloxacin or ciprofloxacin-containing products. In this case-cohort, the dose and length of ciprofloxacin treatment were different between the two studies. Therefore, a meta-analysis of the efficacy and safety of ciprofloxacin in adults should be done to better understand the differences in efficacy and safety between these two studies.
Citation:Mouret E, Kére R, Béart B, Négle R, et al. (2014) In vitro and in vivo clinical evaluation of ciprofloxacin in adults: a systematic review and meta-analysis. PLoS ONE 7(5): e013486. https://doi.org/10.1371/journal.pone.013486
Editor:Régé Lémy, University of Paris Lille, France
Received:November 6, 2013;Accepted:March 20, 2014;Published:June 3, 2014
Copyright:© 2014 Mouret et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding:This work was supported by the University of Paris Hospitals, Centre Hospitalier de Recherches de Pharmaceutique et Pharmacie (C. P. H. S. C. P.), and the French Research Agency (SAB-1038/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests:The authors have declared that no competing interests exist.
The first case-cohort (i.e. all patients receiving ciprofloxacin-containing therapy) was studied in France between September 2011 and October 2014 []. The purpose of the study was to evaluate the efficacy and safety of ciprofloxacin in adults. Since the drug was developed in the 1990s, the development of ciprofloxacin was not restricted to pediatric patients (from whom the drug was available). For this reason, ciprofloxacin was only approved by the FDA in the United States, but the drug was only approved for use in adults by the US Food and Drug Administration (FDA) in August 2008 [].
A total of 5,834 patients were included in this prospective, randomized, double-blind, parallel-group, double-dummy, placebo-controlled, dose-titration study of ciprofloxacin in adults. The patients were randomly assigned in two phases (phase 1: randomization to ciprofloxacin (n = 5,834), placebo (n = 5,834) and ciprofloxacin (n = 5,834). In phase 1, a ciprofloxacin-containing therapy was initiated as recommended by the French Medicines Agency (FA). In phase 2, a second treatment (n = 5,834) was administered. Patients were followed up for a minimum of six months. The patients were followed up for the entire period of 6 months until the end of the study (June 2020).
The objective of the present study was to evaluate the efficacy and safety of ciprofloxacin in adults.
Stade de France Pharmacy